AI in Biotech

Nucleate and idalab are organizing an evening to explore the latest developments in AI along the drug development value chain, from early discovery to clinical translation and beyond. This panel brings together perspectives from a global pharmaceutical company, a clinical-stage biotech, and a venture capital investor. The panel will explore how pharma is integrating AI into large-scale R&D pipelines, how biotech companies are leveraging AI to innovate faster, and what investors look for in AI-driven biotech ventures.

​Panelists

• ​Djork-Arné Clevert, VP & Head of Machine Learning at Pfizer

• ​Jonathan Montagu, President & CEO at HotSpot Therapeutics

• ​Rabab Nasrallah, Principal at Earlybird Health

​Agenda

• ​18:00 - Doors open

• ​18:30 - Panel starts

• ​19:30 - Drinks and networking

Register here.